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ORIGINAL ARTICLE
So let me find my way, whatever it will cost me,
rather than leaving myself in darkness: experiences
of glaucoma in Nigeria
Fatima Kyari1,2*, Clare I. Chandler3, Martha Martin4 and Clare E. Gilbert1
1International Centre for Eye Health, Department of Clinical Research, London School of Hygiene and
Tropical Medicine, London, United Kingdom; 2Department of Ophthalmology, College of Health Sciences,
University of Abuja, Abuja, Nigeria; 3Department of Global Health and Development, Faculty of Public Health
and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom; 4Initiative for
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Background: Blindness from glaucoma is associated with socio-economic deprivation, presumed to reflect
poor access to care and poor adherence to treatment.
Objectives: To determine why people with glaucoma are presenting late for treatment and to understand
access to glaucoma care. Additionally, we sought to identify what patients and the community know, do and
think about the condition and why the poor are the most affected with glaucoma blindness.
Design: Study participants were from four communities and two hospitals in Abuja-FCT and Kaduna State,
Nigeria. A total of 120 participants were involved, including 8 focus group discussions, 7 in-depth interviews
with blind/visually impaired glaucoma patients, 5 rapid direct observation visits with these patients and 13 exit
interviews of glaucoma patients in the hospital. The data were analysed using content analysis, interpreting
participant experiences in terms of three key steps conceptualised as important in the care pathway: what it
takes to know glaucoma, to reach a diagnosis and to access continued care.
Results: This article presents multiple narratives of accessing and maintaining glaucoma care and how people
manage and cope with the disease. People may be presenting late due to structural barriers, which include lack
of knowledge and awareness about glaucoma and not finding an appropriately equipped health care facility.
What keeps glaucoma patients within the care pathway are a good hospital experience; a support structure
involving family, counselling and shared patients’ experiences; and an informed choice of treatment, as well as
agency. The high cost of purchasing care is a major factor for patients dropping out of treatment.
Conclusion: The findings suggest the need to address economic and social structural drivers as glaucoma
presents another case study to demonstrate that poverty is a strong driver for blindness. There is also a need for
clear glaucoma care pathways with early case finding in the community, two-way referral/feedback systems,
well-equipped glaucoma care hospitals and better eye health care financing.
Keywords: glaucoma; blindness; vision loss; late diagnosis; early detection; care pathway; Nigeria
*Correspondence to: Fatima Kyari, International Centre for Eye Health, Department of Clinical Research,
London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom,
Email: Fatima.Kyari@Lshtm.ac.uk
Received: 9 April 2016; Revised: 6 November 2016; Accepted: 8 November 2016; Published: 6 December 2016
Introduction
Glaucoma is the leading cause of avoidable irreversible
blindness globally (1). In Nigeria, the recent national
survey of blindness showed the prevalence of glaucoma to
be high (5%) among adults aged 40 years and above, 94%
of those with glaucoma were undiagnosed and untreated
and one in five were blind (2). Poverty and socio-economic
deprivation are significant risk factors for blindness from
glaucoma (35). In a recent study of glaucoma patients in
north-eastern Nigeria, 76% were already blind when they
presented to the hospital with older age, poor knowledge
of glaucoma, rural residence and living more than 10 km
from the hospital being associated with blindness at pre-
sentation (6). Glaucoma blindness, therefore, reflects dispa-
rity in access to care. Additionally, there is a correlation
between worsening quality of life and increasing severity of
disease (7, 8).
Recent advances in technology for early diagnosis
of glaucoma, greater therapeutic options and possibili-
ties for treatment monitoring reduce the probability of
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blindness among patients in the care system in industria-
lised countries (9). Hence, blindness from glaucoma and
the negative impact on quality of life are avoidable. The
biomedical description of glaucoma is based on a known
set of symptoms and signs including loss of sight, loss
of visual field and raised intraocular pressure. Once the
diagnosis has been made and the disease named, treat-
ment is recommended to prevent further vision loss and
maintain quality of life. Late presentation is when a per-
son presents with biomedically severe/advanced disease in
the worse-affected eye where visual acuity is B3/60, cup:
disc ratio is 0.8 and central visual field is B10 degrees.
In this qualitative study, our main question was why
are people with glaucoma presenting late for treatment,
with severe/advanced disease, rather than presenting with
moderate disease at a point when progression to blindness
can be slowed with biomedical intervention. We also sought
to identify what patients and the community know, do and
think about the condition and why the poor are the most
affectedwith glaucoma blindness. We studied sociocultural
contexts that impinge on the delivery of interventions for
glaucoma. Providing a critical perspective on services
for glaucoma would enable strategies to be developed to
deliver more responsive and, hence, effective interventions
and care, both for individuals and communities most
affected in Nigeria and other sub-Saharan countries with
similar high prevalence of glaucoma who also share similar
socio-economic and socio-demographic characteristics.
Methods
This study employed qualitative methods to assess parti-
cipants’ knowledge and treatment of glaucoma using our
clinical perspective as the benchmark.
Conceptual framework
We conceptualised a framework for an optimal glaucoma
care pathway (see the central flow in Fig. 1) and imagined
that patients should take those steps to avoid blindness.
The pathway involved getting to know glaucoma, having
a diagnosis, accepting the treatment offered, compliance
with treatment and maintaining monitoring and follow-
up. In order to obtain data from multiple perspectives,
the study employed a number of methods: focus group
discussions (FGDs) held in the community, in-depth
one-to-one interviews (IDIs) with blind/visually impaired
glaucoma patients and their direct observation (DOs),
and exit interviews (EIs) of glaucoma patients in the
hospital. This range was selected in order to have a wide
range of respondents at different sites so as to corroborate
findings between people in the community and patients
that have accessed care.
Study area
The study areas were Abuja, Federal Capital territory, the
capital city of Nigeria situated in the central part of the
country; and Kaduna State in the north-west geo-political
zone. Abuja comprises six local councils, two of which
were included in our study: Bwari and Gwagwalada,
in which we included one urban location (Kubwa) and
one rural location (Sheda), respectively. In Kaduna, we
included one urban location, Tudun Wada, and one rural
location, Sabon Birni. Both areas have government and
mission hospitals that provide eye care. We selected two
hospitals that provide glaucoma services, one in each of
the two areas. Hospital 1, located in Gwagwalada, Abuja,
is mission-run, and Hospital 2, located in Kaduna, is
government-owned.
Natural history
Current situation
Not known Earlydetection Diagnosis
Start
treatment
Accept/
continue
treatment
Follow-up and
monitor
Optimal care pathway Knowing, access to care, accepting treatment, maintaining treatment
How people get into the care pathway
Why patients drop out of the care pathway
What keeps patients in the care pathway
Poor vision-advanced/severe
Fear of the effect of vision loss
Referred from outreach
Invited for examination by FDR
Unpleasant experience with TEM
Knowing glaucoma
Not knowing the disease
Not understanding the possibility
      of further vision loss
Offered alternate nonmedical therapy
No one word for “glaucoma”
Reaching a diagnosis
Not getting a diagnosis
Not knowing where to find care
Far distance from hospital
Lack of access to information
Hospitals not adequately equipped
Late diagnosis
Accessing on-going care
High cost of care
Not understanding the treatment
Unrealistic medical instructions
Multiple opinions in different hospitals
Loss of economic productivity
Pleasant hospital experience
Treatment is explained
Surgery outcomes are explained
Accept treatment
GPA-support and
   shared experiences 
Agency; and can take decisions
Can afford treatment
Maintain follow up
Adequately monitored
Accepting possibility of further vision
    loss without treatment
Late diagnosis; treatment noncompliance; failed follow-up
Gradual visual loss and progression to blindness
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FDR = first degree relative; TEM = traditional eye medication; GPA = glaucoma patient association
Fig. 1. A conceptual framework for the glaucoma care pathway.
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Participant selection and sample size
The study was based on eight FGDs held in the commu-
nity, seven one-to-one IDIs with blind/visually impaired
glaucoma patients, five of whom were directly observed
in the community, and 13 EIs of glaucoma patients in
the two selected hospitals (Fig. 2), consisting of a total of
120 participants. The fieldwork was conducted between
January and March 2012.
The study team consisted of the researcher who is also
the first author (FK) of this article, research assistant,
also a co-author (MM), and the note-taker/field assis-
tant. The two assistants were trained for data collection
in health care research. Training of the assistants by the
researcher included a discussion on the overview of the
study aim and objectives, procedures, participant recruit-
ment and interview/discussion techniques, and possible
challenges and how to overcome them.
Purposive sampling was used to select hospitals
and participants. Community-based research facilitators
(HR, CO, FE and ES) were involved in selecting the four
communities outlined above. The research assistant to-
gether with the community-based facilitators, who were
involved in community-based rehabilitation of patients
with disability or had been on outreach, identified and
recruited the participants in the community for the FGDs
and the IDIs (and DOs). There were two local ophthal-
mologists (FA and TN) who facilitated the selection of
participants for the EIs in their hospitals. No incentives
were provided to participate, but all were offered free eye
examination and referral where necessary and refresh-
ments were provided.
Discussions and interviews were conducted in English,
Hausa or Pidgin English by FK or MM accompanied by
the note-taker, with little need for an interpreter as both
interviewers were multilingual in the languages of discus-
sion. However, one FGD and one EI were conducted in
Gbagyi where a translator was required. All interviews/
discussions were recorded with a digital recording device,
and notes were taken.
Focus group discussions
Two FGDs with members of the community were held
in each of the four communities, that is, total of eight
FGDs, conducting separate discussions for female and
male groups in order to have a relaxed atmosphere and
foster openness. Participants were aged 30 years and above
and included a community leader, visually impaired/blind,
and normal-sighted community members. The FGDs
were held in a convenient private meeting area within the
community. Written informed consent was obtained from
participants after explanation of what would take place
and their basic demographic data were recorded.
A topic guide was followed in order to stimulate dis-
cussion and bring out potential factors exploring the
knowledge and practices in relation to eye diseases and
blindness in general, and glaucoma in particular, their
perception of risks and concept and understanding of
blindness. We also explored their health-seeking processes.
After each FGD, the study team reviewed the audio
recording, and challenges and need to include more pro-
bing questions were discussed.
In-depth interviews
IDIs were conducted with glaucoma patients in the
community who were visually impaired or blind and had
not accessed treatment or had had treatment whether
successful or not. The IDIs were conducted in the
participant’s home in a place which provided privacy. We
carried out IDIs using a narrative approach: ‘tell me about
your eye problem/disease . . .’ and with a topic guide
for prompt questions in order to explore participants’
knowledge about their disease, what symptoms triggered
them to seek care, difficulties in seeking care, their
perception of glaucoma as a cause of blindness and the
cost of finding care.
Direct observation
DO involved shadowing the participants to observe how
their everyday lives were affected, particularly with regard
Hospital 1 Hospital 2
Tudun Wada (U)
n = 16 n = 6 n = 8 n = 14      
IDI+DO blind IDI+DO blind IDI blind IDI+DO blind IDI blind
8 FGDs in the community total
participants n = 101
Total - 28 interviews
7 IDIs in the community of which
5 also had DO
IDI+DO blind IDI+DO blind
Summary
Total participants = 120*
*one participant had IDI+DO and
Exit Interview
U = urban; R = rural; FGD = focus group discussion; IDI = in-depth interview; DO = direct observation.
Sabon Birni (R)
Kaduna StateAbuja-FCT
Exit interviews
with 8 patients
Kubwa (U)
FGD1 females FGD2  males FGD3 females
Sheda (R)
FGD4  males FGD5 females FGD6 males
n = 15 n = 15
FGD7 females FGD8 males
n = 1 n = 16
13 Exit Interviews in the hospital
Hospital 1, Gwagwalada, Abuja
Hospital 2, Kaduna
Exit interviews
with 5 patients
  
 
Fig. 2. Sampling strategy and sample size for the patient and community perception study.
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to their home environment and interactions within the
community. We selected IDI participants who gave us
the opportunity to observe them in their homes. We
had a checklist of observations, which included how they
interacted with their family members and how members
of the community approached and related with them. We
also observed how independent they were in terms of
mobility, use of everyday gadgets such as mobile phones
and telling the time.
Exit interviews
One-to-one EIs were conducted, and participants were
asked to narrate their experience of the hospital visit and
what they felt about the diagnosis and treatment. This also
included their positive experiences, rather than only
barriers to accessing health care. They were also asked
about triggers that led them to seek care, whether their
condition was explained to them and what they under-
stood about glaucoma and the effects of their sight loss on
their everyday lives, and how much money they had spent
on eye care. They were also asked about their know-
ledge and use of traditional (non-medical) eye medication
(TEM) and what they would tell new patients who had
been diagnosed with glaucoma. Participants ranged in age
from 29 to 74 years.
Data handling and analysis
The audio recordings were transcribed in the language of
discussion. Hausa transcripts were translated into English.
English translations were crosschecked and finalised by
FK. English transcripts of FGDs, IDIs (and DOs) and EIs
were imported into NVivo 10 (QSR International Pty Ltd.,
Victoria, Australia). The data were accessible to only the
researcher and co-authors.
Data immersion
The researcher became familiar with the data through
conducting, transcribing and translating most of the inter-
views. Transcripts were read carefully and coded line by line.
The data were analysed using content analysis, inter-
preting participant experiences in terms of three key
steps conceptualised as important in the care pathway:
‘knowing glaucoma’ which gave a perspective of people’s
experience and not compared to what they should know;
‘reaching a diagnosis’ which stems from knowing glauco-
ma and as a prerequisite for treatment; and ‘accessing on-
going glaucoma care’ which includes issues of cost of care,
decisions on treatment and non-medical alternatives that
people might be offered. Within each step, we identified
explanatory themes. The themes were developed based on
initial reading through the transcripts. A coding template
was set up for the three themes that emerged from the
data and agreement of categorisation reached through
discussion and review by the co-authors (CC and CG). We
remained open to additional codes and new themes that
emerged during analysis. Additional codes were applied in
order to identify what it really meant to people to have
glaucoma and how debilitating it was. Initial coding was
done by hand, and subsequent categorisation and archiv-
ing were done using NVivo 10 (QSR International).
Ethics
Ethical approval was obtained from the Ethics Committee
of the London School of Hygiene and Tropical Medicine,
UK, and the Nigeria National Health Research and Ethics
Committee. Written informed consent was obtained from
the participants. We specifically asked to record interviews,
take photos and use anonymous quotes. Confidentiality
and anonymity were maintained. The study did not
interfere with any treatment that patients were receiving.
Participants in need of further management for their eye
condition were attended to and referred to the appropriate
facility if necessary.
Results
Study participants
All participants in the FGDs (n101) were aged 30 years
and above (Table 1). Basic demographic characteristics of
the IDI and EI participants (n19) are shown in Table 2.
The findings represent narratives of accessing and
maintaining glaucoma care and how people managed
and coped with the disease. It is important to know that
from many people’s perspective, there is no care pathway;
it is just life, the lived reality. Thus, other aspects we
explored were the coping mechanisms of patients with
glaucoma and the consequences of fear of the effect of
sight loss, feelings of isolation, abandonment, stigmatisa-
tion and loss of autonomy as well as financial stress and
loss of economic/social productivity. The coping mechan-
isms were within sociocultural constructs of faith in God
and support from family, friends and community. It was
not only about coping with the disease, but also about
coping with the social situation they were in.
Some quotes have been paraphrased to ease reading
without losing the context and meaning captured in the
discussion. Furthermore, four cases are presented to
illustrate the different themes.
Knowing glaucoma
Blindness is generally considered a serious problem.
However, participants avoided use of the term ‘blindness’
or ‘makanta’ (Hausa), rather they would say ‘eye problem’
or ‘matsalar ido’ (Hausa). Participants’ description of
blindness often indicated a total loss of vision, attaching a
morbid reality to it, while those with poor vision did not
always define themselves as blind.
There was generally poor knowledge of eye diseases as
understood in biomedicine and lack of access to informa-
tion. Most participants got information about health
Fatima Kyari et al.
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issues from the radio. Other sources are places of worship
(church and mosque), through reading and interaction
with neighbours or health workers. They, however, would
rely on information given them by the doctor or at the
hospital during health talks. They described symptoms
without giving specific names for eye disease except for
cataract (yana) and corneal opacity (hakiya), though
sometimes they interchanged description of the two.
Most participants had not heard about glaucoma, and
they recognised that self-medication with inappropriate
medicines would cause delay in seeking treatment.
None of the patients had heard of the term ‘glaucoma’
before their diagnosis. They did not bundle their symptoms
and experiences as a disease entity, and there was no
reference to any biomedical category. Some of their
symptoms such as redness and tearing were often con-
sidered to be common and less sight-threatening eye
conditions. Different things happened over time, such
that by the time they sought treatment, there was severe
vision loss in at least one eye. Participant EI-8 said
‘I cannot see very well. Like I am in the dark’, and EI-4
felt indeed glaucoma is a silent thief of sight.
People’s experiences differed, and some participants
came to know things were not quite right with their
vision, some of which may indicate visual field loss. For
example, not being able to see the right underarm while
shaving was illuminating for EI-1, whereas EI-13 could
only see clearly through the corner of the eye, and IDI-7
could not see people’s body completely.
Factors related to not knowing glaucoma included
stigma around blindness and poor vision so that they
would not talk about it; misconceptions on causations of
eye diseases; and general lack of awareness, knowledge
and access to information about glaucoma and eye
diseases. These factors led many participants in the care
system to present with late disease and to access multiple
opinions in different hospitals, hopping and hoping.
Reaching a diagnosis
Knowing glaucoma is part of reaching a diagnosis. Even
when they got to know they have glaucoma, some have no
information on what to do about it. In health care centres
where there are no trained health-workers or appropriate
equipment, then one cannot make a diagnosis of glaucoma.
Participants did not have a designated entry point
into clinical care, and there was no system of referral.
Participants did not know where to find care or what
treatment to expect nor did they appreciate the possibility
of future sight loss without treatment, which led some to
visit multiple providers  going from one health facility
to another. As IDI-5 experienced: ‘I kept going (to the
hospital). Then, the hospital was moved to Shika. Then
I started going to Eye centre. Thereafter I went to Dan
Tsoho. I was n’t satisfied, so I went to Zaria. Then I was
told that there was a hospital in Kano. I started going there.
I was not comfortable so I changed to another hospital,
right there at Kano’.
The high cost of finding care contributed to these
difficulties, but EI-11 had agency and was determined to
find and maintain care (Box 1). On the contrary, inability
to make autonomous decisions for one’s own benefit
contributed to delays in making a diagnosis (see Box 2:
IDI-2). Some participants mentioned distance to hospital
was a reason for their poor access to care and felt they
had no bargaining power and could not request for
services to be brought closer to them.
Thus, the contributory factors for late diagnosis include
poor knowledge about the disease, not finding an appro-
priately equipped hospital and inability to afford care.
Table 1. Demographic characteristics of participants of
focus group discussions in the community
Number of participants (%)
Rural
(Sheda and
Sabon-Birni)
Urban
(Kubwa and
Tudun-Wada) Total
Gender
Female 19 (39) 31 (60) 50 (50)
Male 30 (61) 21 (40) 51 (50)
Age (years)
3045 6 (12) 11 (21) 17 (17)
4660 17 (35) 17 (33) 34 (34)
61 and older 4 (8) 22 (42) 26 (26)
Not indicated 22 (45) 2 (4) 24 (24)
Occupation
(current/retired)
Civil service
officer
 6 (12) 6 (6)
Driver  2 (4) 2 (2)
Farmer 9 (18) 1 (2) 10 (10)
Housewife 6 (12) 16 (31) 22 (22)
Military  1 (2) 1 (1)
Office assistant/
cleaner
1 (2) 3 (6) 4 (4)
Student  1 (2) 1 (1)
Teacher/lecturer 2 (4) 3 (6) 5 (5)
Trader/business 3 (6) 16 (31) 19 (19)
Not indicated 28 (57) 3 (6) 31 (31)
Total participants 49 (100) 52 (100) 101 (100)
Language of
discussion
English  2 (50) 2 (25)
Gbagyia 1 (25)  1 (12.5)
Hausa 3 (75) 2 (50) 5 (62.5)
Total FGDs 4 (100) 4 (100) 8 (100)
FGD, focus group discussion.
aAn interpreter was used in this FGD.
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Accessing and maintaining glaucoma care
Hospital experiences varied considerably. However, a
good hospital experience and obtaining appropriate
information made a difference in patients’ understanding
of their disease and gave them hope.
Family members are cardinal in decision-making for
choice of treatment options, and participants would often
discuss with them before taking decisions. Thus, patients
and their carers/family need to fully understand the dis-
ease and the implications of choices of treatment. Once a
diagnosis of glaucoma is made and choice of treatment is
considered, physicians need to discuss treatment options
with the patient and family. This is also helpful for
identifying first-degree relatives with glaucoma. IDI-4’s
older brother was already blind at the time of diagnosis.
IDI-4 also had late diagnosis and could not sustain
medical treatment, and he gradually became blind. His
younger brother was also diagnosed late but had surgery in
the only seeing eye and this helped to maintain his vision.
Some participants had unpleasant experience with TEM
(see Box 3: IDI-6).
Hospital charges and cost of medicines were a great
concern, and in some cases, these contributed to poor
compliance with medical therapy. IDI-4 could not keep up
with buying medicines due to cost, and IDI-7 lamented
that all he had spent was to no avail. Inability to afford
hospital costs precluded patients from getting and main-
taining treatment. FGD/4/P6 mentioned ‘Actually, in the
hospital, they asked me to pay about N60,000 (£240). But
with that amount of money requested, I just put the paper
in my pocket and went back home. One who has not even
N100 (£0.40p) at home, they ask for N60,000 (£240); how
can you even begin to get that?’ On the contrary, EI-4
alluded to the availability of health insurance as being
beneficial for enabling access.
In terms of getting information about their disease,
some perceived a hierarchical doctorpatient relationship
characterised by one-way communication, with the patient
Table 2. Basic demographic information for the participants who had in-depth interviews in the community and exit interviews
in the two selected hospitals
No. Code Gender
Agea
(years) Occupation Available clinical description
1 IDI-1; EI-2 F 62 Housewife (military) VA: RE 6/9, LE HM; BE CDR 0.9
2 IDI-2 M 60 Retired as military nurse VA: NPL BE; BE CDR 1.0
3 IDI-3 M 59 Stopped driving VA: NPL BE
4 IDI-4 M 45 Trader VA: RE PL, LE NPL
5 IDI-5 M 75 Butcher VA: RE CF, LE 6/9; RE CDR 1.0, LE CDR 0.9; LE
trabeculectomy 12 years
6 IDI-6 F 67 Housewife BE not seeing. Sees some shadows
7 IDI-7 M 43 Teacher VA: RE NPL, LE NPL; Diagnosed glaucoma and had RE
trabeculectomy 9 years ago; then had RE vitrectomy for
endophthalmitis 6 years later
8 EI-1 M 29 Works with a trading company RE not seeing
9 EI-3 M 56 Stopped work RE cloudy; LE not seeing
10 EI-4 M 52 Senior civil servant (Intelligence
department)
Diagnosed glaucoma 8 years ago; Had triple procedure in
first eye and trabeculectomy only in second eye
11 EI-5 M 40 Farmer LE not seeing
12 EI-6 M 74 Lecturer at college of education One eye blind since early adulthood. Had cataract surgery
and diagnosed glaucoma in the only eye
13 EI-7 M 58 Electrician, works with contractor firm One is bad. Diagnosed glaucoma more than 5 years ago
14 EI-8 M 60 Farmer RE not seeing clearly; had RE trabeculectomy
15 EI-9 F 53 Theatre nurse RE worse; had RE trabeculectomy
16 EI-10 M 53 Worked in telecommunications. Made
redundant due to company closure
BE seeing ok
17 EI-11 M 42 Vehicle insurance officer (civil servant) LE not seeing  had surgery in LE prior to diagnosis of
glaucoma in BE
18 EI-12 M 70 Dependent on children RE not seeing
19 EI-13 M 62 Mechanic, contractor One sees well, other not much
IDI, in-depth interview; EI, exit interview; VA, visual acuity; RE, right eye; LE, left eye; HM, hand motions; BE, both eyes; CDR, cup-to-disc
ratio; NPL, no perception of light; PL, perception of light; CF, counting fingers.
aSome ages were estimates.
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not having courage to ask for explanations. Some partici-
pants felt this was because clinicians have enormous social
responsibilities despite their busy work schedule and much
is expected from them. Rather, they were satisfied with a
one-to-one guidance and counselling on their disease.
Having a forum such as a glaucoma patient association
would promote interaction between patients, with repre-
sentation for actively addressing challenges in accessing
care and treatment and obtaining social support. Parti-
cipants believed that shared experiences would enhance
ability to make informed choices and staying in treatment.
What keeps glaucoma patients within the care pathway
are a good hospital experience; a support structure in-
volving family, counselling and shared patients’ experi-
ences; and an informed choice of treatment, as well as
agency  knowing about glaucoma and being able to do
something about it. The cost of treatment is a major
factor for patients dropping out of treatment.
Having glaucoma and coping mechanisms
IDI-2 expressed feelings of isolation and abandonment
and loss of value to his children and friends (see Box 2),
while some participants note that their visual impairment
should not define who they are. IDI-5 felt awful for being
called ‘blind-man’ (makaho). Likewise, IDI-7 who had
been active in the community for about 40 years disliked
being addressed as ‘blind-man’ (makaho): ‘why would
people address me as such and alienate me?’
A diagnosis of glaucoma triggered anxiety: EI-1 said,
‘I had a breakdown. A shock went through my spine’; or
Box 1. EI-11 illustrates late presentation, getting to know
glaucoma, agency, accepting the possibility of further vision
loss without treatment and maintaining continued care
EI-11 is a 42-year-old senior civil servant:
When I discovered that I had eye problem . . . one eye
was seeing, one eye was not seeing, I said I cannot
continue like this, let me find my way to FMC but
I was stopped by a friend who recommended a private
clinic. I did not know it was run by a nurse. There,
I was told I had glaucoma. He did not give much
guidelines and explanation. Had I got guidelines and
explanation, it would have not reached up to this
stage at which I am in now. Later, after one year plus,
I changed to a private doctor. He also said I had
glaucoma and one of my eyes was severely affected.
That is the left eye. Then he explained glaucoma. And
ah, that’s how I started to know about glaucoma.
Because at the private hospital, . . . you will spend
much and much and much and much. I asked him to
give me a referral letter to NEC. He said ‘why refer if
it’s what I can do?’ Though he’s a qualified doctor,
he’s a doctor. Then I later thought it over . . . I said
kai . . . (sigh) I’m educated so let me find my way.
Whatever it will cost me, let it cost me rather than
leaving myself in darkness. And I don’t want to be in
the dark!
Here, they explained ALL (his emphasis) things to
me. And they said ANY (!) nerves, or ANY (!) eye
sight that glaucoma destroys, it is destroyed for life.
So that’s why I said I cannot stay and continue
looking at it . . . then leaving myself in darkness.
Because I am still young, I don’t know how long
I will live in the world and my eye . . . Then that I’m
finished. So that’s why I normally maintain the
period I’m given for appointment. I don’t fail it.
I don’t fail it. Yes.
Box 2. IDI-2 illustrates lack of autonomy to take
decisions, not understanding the treatment and feeling
of abandonment but accepting the situation he is in
IDI-2 retired as a staff sergeant after 35 years in the
military as a nurse. He is blind in both eyes from
glaucoma. He is a widower and lives with 3 of his
5 children, the youngest being 11 years old. The
oldest son is away on military service, and the oldest
daughter is at University. Interviewing him was my
second IDI of a blind person in the community.
‘When I was diagnosed with glaucoma in 2004’, the
doctors suggested surgery. However, my preparation
for retirement from the military stopped the discus-
sion of surgery. Then things happened so quickly 
I was retired, had to leave the barracks official
accommodation to my uncompleted house which
was yet to be roofed. ‘At the time I moved to this
place I could see and move around everywhere’. That
was 2007.
‘At the hospital, I had been receiving treatment
but there was no improvement. I went to another
hospital’. I continued treatment until I got fed up . . .
‘Anywhere I went, they would say timolol, timolol . . . ’
When asked about how he copes being blind 
‘It is not easy . . . The children would just go away.
Not that we don’t have . . . I have television, DVD,
radio, anything that can make them happy to stay
here. I don’t shout at them  there’s food, everything.
I don’t know why . . . I’m not having peace of mind
again. As I cannot see anything at all how can I go out
myself? There is nothing I can do . . . The challenge is
too much but there is nothing I can do. What can I do?
Do I cry? If I cry, am I the first person to go blind?
So there is nothing I can do than to accept it like that.
So I have to thank God very well. ‘It is said in the
Bible that in any situation you see yourself, accept it’.
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perhaps regarded as a fate worse than death because ‘some
people prefer to die instead of living with blindness’ (EI-4).
There was also an emotional component as IDI-1 kept
sobbing during the interview while saying ‘God, you know
better, you will make it better’. Participants who had lost
vision expressed their dismay in their inability to do certain
tasks especially driving, writing and keeping their jobs.
Some also had feelings of being a burden on those who
assist them in their everyday activities.
Within the sociocultural framework of faith in God,
some glaucoma participants did not see themselves as
being blind and now suffering. Rather, they found ways
to manage the situation. FGD/4/P3 said ‘I put my trust in
God’ (see also Box 4: IDI-7). IDI-4 remains an important
member of his community as the Imam who leads the
congregation prayers in the local mosque. He finds
strength in faith and accepts that everything in life would
be left behind anyway.
Discussion
This study found that most people do not know about
glaucoma, they are not aware when they have it, they do
not know where to find care and they are faced with
challenges in accessing and maintaining treatment because
of poor infrastructure and high cost of care. A major
trigger of seeking care was advanced loss of sight resulting
in late diagnosis. Indeed, a person with glaucoma may
frequently be unaware of the gradual loss of sight (10, 11).
Loss of sight was often not discussed, and participants did
not use the word ‘blind’ (‘makanta’ in Hausa) to describe
Box 3. IDI-6 illustrates lack of access to medical care,
use of traditional eye medication and not understanding
treatment
IDI-6 is a 67-year-old housewife. Her husband is
the District Head. She is blind in both eyes from
glaucoma. She has never been to a hospital/clinic nor
been on biomedical treatment:
‘My eyes kept hurting and hurting and then they
brought me some perfume which I sprayed on the
eyes. But they got worse. Then they said I should take
a frog and rub it on the eyes. I said I couldn’t do that.
Then my husband picked up the frog and rubbed it on
my eyes and when he threw the frog, it died. The eyes
got better, there was no pain again. Then they gave me
kohl which I kept applying for months and years and
the vision continued dimming and getting worse.
Now, that is my story’.
Asked why she didn’t go to the hospital 
‘I have not been to hospital. The first time they came
(on outreach), I was told I needed operation. But
some people said to my husband that if I went, they
would sever my eye nerves (za’a tsinke jijiya) so
I refused to go since then’.
Box 4. IDI-7 illustrates late diagnosis, difficulties in main-
taining care, poorly equipped tertiary hospital, agency
and coping mechanisms
IDI-7 is a 43-year-old man, civil servant.
‘In 2003, the doctor said my left eye had end-stage
glaucoma. I never knew that it was not seeing before
I went to the hospital. It was when they tested me that
I knew. They recommended surgery for the right
eye. I had the first surgery in 2003 and continued to
see without any problem. I would go for check-up
regularly. Four years later in 2007, my seeing right eye
got reddish. I got worried and went to see the
ophthalmic nurse who recommended an eye drop.
It was not available in my town so I bought it about
30 miles away. I saw my vision diminish gradually . . .
The following day I went to NEC. I needed vitrect-
omy but they didn’t have the materials. Through a
cumbersome process of referral, appointment and
solicitation of funds, I had vitrectomy in Cairo,
Egypt, two weeks later’.
‘My work keeps me busy. Currently I am heading a
centre that teaches secondary school students English
and Mathematics. We recruited 12 lecturers and we
have about 6 classes with over 65 students’.
However, he expressed disturbing limitations as a
public speaker and teacher. ‘You know when I address
people, the only response I can hear from them is
laughter or their voices, but I cannot see their eyes . . .
That is one of my problems. Some people do not talk,
but you can read them from their faces. But I cannot
read those because I cannot see. It is only when
somebody talks that I begin to know his feelings
about me, so that is one of the disturbing things’.
‘It has stopped me from furthering my studies,
Masters. After the first surgery, I could not read . . .
But most importantly, I was not sacked from my job 
that is a happy thing. I earn my salary and maintain
my family’.
On his relationship with his family and community:
‘My family and friends have been very, very suppor-
tive. Especially my wife . . . The community too.
If people could remove this sickness from me, the
number of people that trooped into this house when
I came back from hospital, they would have removed
the sickness from me, on sympathy basis, I tell you . . .
I gave everything to God’.
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themselves. This silence can be seen to have allowed
glaucoma to thrive without being diagnosed. As in Ghana
(12), there was no specific name for glaucoma in the
communities we studied. Similarly, the knowledge of
glaucoma was low, as documented in previous hospital-
based (1316) and population-based (1720) studies. Even
in some developed economies, knowledge of glaucoma
varies (21, 22). The lack of knowledge might have con-
tributed to difficulty in appreciating the possibility of
future sight loss if left untreated even though patients
would live with future uncertainties (23). However, it was
not only the silent nature of loss of sight due to glaucoma
that precluded participants from finding or securing early
care but also additional factors such as not knowing
where to find care and not being able to afford or sustain
care. In a study, where care is available and accessible, every
patient followed up in a population-based survey had
sought eye care (24), but the understanding of glaucoma
was limited (25). In our study, those who had more agency,
that is, resources and ability to take autonomous decisions,
appeared to have found ways to access care.
In line with the United Nations resolution on Universal
Health Coverage (26), a Global Action Plan (GAP) was
developed for eye care (27). GAP aims to ensure that
the diseases that cause blindness and visual impairment
are addressed through universal standards of eye care,
tailored according to local contexts and benefits of modern
medicine. The GAP, inherently linked with vision 2020
‘The Right to Sight’ (28), recognises the need to address
problems of unequal access to eye care and to support
weaker nations/communities to achieve those standards.
This study provides information that will be useful to
developing strategies for locally relevant eye care tailored
towards optimal care.
In interpreting our findings, we identified the concept
of structural violence as a useful way to understand
and explain what could be causing people to be in the
situation of lack of knowledge, late presentation and drop
out from continued care. Structural violence originates
from the perspectives that there is a disease and that the
disease is disabling  for example, HIV/AIDS and there
are structures that make the disease worse in others and
structural inequalities that prevent access to care (29).
When there are constraints and inequalities in socio-
economic status and health systems structures, as we note
here, that preclude avoidable blindness from being
avoided, then there is structural violence (30). Put more
succinctly, ‘structural violence is one way of describing
social arrangements that put individuals and populations
in harm’s way. The arrangements are structural because
they are embedded in the political and economic
organization of our social world; they are violent because
they cause injury to people (typically, not to those res-
ponsible for perpetuating such inequalities) . . . neither
culture nor pure individual will is at fault; rather,
historically given, and often economically driven pro-
cesses and forces conspire to constrain individual agency.
Structural violence is visited upon all those whose social
status denies them access to the fruits of scientific and
social progress’  Paul Farmer (29, 31). The concept of
structural violence encourages us to reorient ourselves
towards finding solutions, to critically engage the realities
and recognise the situation due to structural inequalities
and structural barriers, which cause harm, rather than
passively accepting these as systemic inequalities (32).
These structures of inequalities are invisible and em-
bedded within the same political and economic systems
such that no one individual or institution can be held
accountable (31). For example, if a person goes irrever-
sibly blind from glaucoma, which is avoidable, one might
ask, who do we hold culpable?
In terms of agency, autonomy is related, partially, to
having the ability or the resources to act freely. From the
economic aspect, it could mean those who have a voice 
for example, EI-11: ‘this is what I want’, wherein the
socio-economic structure enables him. However, when
people are unable to demand, the only agency they may
have is to lament and leave  for example, IDI-2: ‘what
else can I do?’ For those who had relatively better agency,
for example, EI-11, they were able to seek care and
navigate the difficult care pathway ‘rather than remain
in the dark’. That was an active response. A somewhat
passive response is accepting the situation and not taking
a decision to go for a biomedical or traditional medicine
but manage the ‘misfortune’ (e.g. IDI-6) and readjusting
their social and family interactions (33, 34). This may not
necessarily be interpreted as social suffering in the way
people manage adverse situations, but takes into con-
sideration coping mechanisms. The way they cope and
the way they accept their situation might be because of
the absence of care or structures that mean they cannot
access care and they do not feel or know that getting
better care is their right. It appears that health choices
have been left to ordinary people to continue their own
therapies, be it traditional medicine or self-medication
from patent medicine stores or markets. This has been
described as ‘subsistence’ health  where people are left
to seek their own care (35), and traditional medicine
is often sought where there were no alternative sources
of treatment (36). In glaucoma, there is no system, no
diagnostic category and no way of well-established man-
agement of the disease within traditional medicine. In fact,
the more established practice of couching, which is the
traditional manual manipulation for cataract, is widely
practiced in Nigeria with very poor visual outcomes (37).
Furthermore, the narratives imply that whether one
goes to the hospital or gets treated was a matter of fate
and destiny, depending on the will of God. In a way, this
submission to the will of God breeds acceptance of the
situation. Some believe that loss of their sight is a test of
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their faith and perhaps an expiation of sins for a better
life after death. Of note, however, is that coping may be a
response to the absence of care or the structures that
mean they cannot access care. This makes the coping
mechanisms dynamic  people have resources and ability
to manage the situation but they would not turn down
the opportunity to have better care that is well explained,
accessible and affordable.
Limitations
There are limitations of this study. The analysis was
undertaken using the transcripts of translation to English
for three-quarters of the discussion. As such, some distinct
expressions might have been lost in translation. Another
limitation is that we conceptualised a care pathway and
saw people who are not accessing or who are falling out
of our imagined pathway. But from their perspective, there
is no care pathway; for them, it is just life, embodied as
lived realities. Additionally, a limitation of the structural
violence perspective is that it labels one with a defining
feature, for example, the glaucoma blind, whereas these
patients did not see themselves as such.
Recommendations
This population-based study provides a baseline and
deeper understanding of access to glaucoma care. How-
ever, we recommend conducting a similar study in different
settings for local content. A further recommendation is
that in addition to offering biomedical/clinical service,
providers need to collaborate and communicate effectively
with patients, family members and carers so that they
understand the disease, manage their expectations and be
effectively supported to gain insight into the disabling
consequences of blindness. Other needs are better eye
healthcare financing, visual rehabilitation and social
adaptations for people with visual impairment/blindness.
A social policy and disability benefits would also ease
some of the social suffering of blindness.
Conclusion
In Nigeria, the reasons for late presentation imply the
need for improving services for glaucoma. Availability
and affordability of treatment need to be addressed so
that hospitals are well equipped to manage glaucoma,
incorporating early case-detection strategies with clear
glaucoma care pathways and two-way referral/feedback
systems.
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Paper context
Blindness from glaucoma is associated with late presentation
and poor compliance to treatment. This study indicates that
late diagnosis may be explained by structural barriers to
accessing care: socio-economic deprivation, poor under-
standing of the disease and high cost of care. The findings
suggest the need to address socio-economic structural drivers
as glaucoma experiences demonstrate that poverty is a strong
driver for blindness. There is also a need for clear glaucoma
care pathways and better eye healthcare financing.
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